The multilineage hematopoietic effects of IL-3 appear to be most important for its clinical use comprising especially leucocyte and platelet responses. This was demonstrated to be dose dependent characterising doses of 250 to 500 micrograms/m2/day subcutaneously as hematopoietic effective and well t
Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: A potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro
✍ Scribed by Z. Estrov; R. Kurzrock; M. Talpaz; M. Blake; J. U. Gutterman
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 457 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Interleukin-3 (il-3) and granulocyte-macrophage-colony stimulating factor (gm-csf) have synergistic, hematopoietic growth-promoting activity in preclinical studies. because of the paucity of effective therapies for patients with chronic bone marrow failure states, the authors studied
The production of granulocyte-macrophage colony-stimulating activity (CSA) by isolated murine femur shafts, non-dispersed bone marrow and spleens was assessed following administration of Vinblastine (VLB). These organs were removed from 2 h to 10 days post-VLB and allowed to condition endotoxin-free
## Abstract The roles of colony‐stimulating factors in long‐term bone marrow cultures were studied and compared. After single additions of high concentrations of unpurified colony‐stimulating activities to the cultures, rapid deterioration of the cultures was observed. This appears to result from c